GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Other Operating Expense

Ind-Swift Laboratories (NSE:INDSWFTLAB) Other Operating Expense : ₹2,548 Mil (TTM As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Other Operating Expense?

Ind-Swift Laboratories's Other Operating Expense for the three months ended in Dec. 2023 was ₹939 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹2,548 Mil.

Ind-Swift Laboratories's quarterly Other Operating Expense declined from Jun. 2023 (₹1,017 Mil) to Sep. 2023 (₹928 Mil) but then increased from Sep. 2023 (₹928 Mil) to Dec. 2023 (₹939 Mil).

Ind-Swift Laboratories's annual Other Operating Expense increased from Mar. 2021 (₹1,830 Mil) to Mar. 2022 (₹2,201 Mil) but then declined from Mar. 2022 (₹2,201 Mil) to Mar. 2023 (₹1,953 Mil).


Ind-Swift Laboratories Other Operating Expense Historical Data

The historical data trend for Ind-Swift Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Other Operating Expense Chart

Ind-Swift Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,951.38 1,887.64 1,830.20 2,200.68 1,953.50

Ind-Swift Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 917.24 -335.16 1,016.62 927.53 939.45

Ind-Swift Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,548 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ind-Swift Laboratories Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Traded in Other Exchanges
Address
SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101
Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines